Loss-of-function genetic screens with pooled sgRNA and shRNA libraries aid in discovery / prioritization of drug targets, understanding of disease progression and gene-disease associations, analysis of signal transduction pathways, characterization of the mechanisms for compounds, uncovering of synergistic gene interactions, and identification of markers of drug resistance and sensitivity. This webinar presents a comparison of loss-of-function genetic screens performed with CRISPR versus RNAi technology.
Recommended Videos
How Do Our Bodies Fight Off Dangerous Chemicals?
VideoUC San Diego's Amro Hamdoun explains how you can think of cells like night clubs. With every substance that a cell encounters it has to decide which to eliminate and which to let in. Since humans have generated over 80,000 synthetic compounds, it's now ever more important to.
WATCH NOWGarbage In = Garbage Out: Limited Peer Review in Cannabis Sequencing
VideoMany companies are offering DNA sequencing for the cannabis field but not all of these companies have scientific staff that have published genomics papers. Do they know how to sequence? This recent review implies, in some cases, they do not.
WATCH NOWThe Fascinating World of Crystallography
VideoTake a trip through the development of crystallography.
WATCH NOWComments | 0 ADD COMMENT
Like what you just watched? You can find similar content on the communities below.
Drug Discovery Genomics Research Proteomics & MetabolomicsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
Login
You must be logged in to post a comment.